SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-241295
Filing Date
2018-08-07
Accepted
2018-08-07 17:16:58
Documents
5
Period of Report
2018-08-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d571470d8k.htm 8-K 16350
2 EX-99.1 d571470dex991.htm EX-99.1 11182
3 EX-99.2 d571470dex992.htm EX-99.2 63455
4 GRAPHIC g571470g0808012220043.jpg GRAPHIC 4937
5 GRAPHIC g571470g0808012439243.jpg GRAPHIC 4937
  Complete submission text file 0001193125-18-241295.txt   106265
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 18999085
SIC: 2834 Pharmaceutical Preparations